Drugs / BAY1179470
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01881217 | Jun 2013 → Mar 2016 | neoplasm | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1179470 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01881217 ↗ |
| Route | Intravenous | “BAY1179470 will be administered as a 1-hour intravenous infusion.” NCT01881217 ↗ |